Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 2;13(1):201.
doi: 10.3390/nano13010201.

Advances in the Mechanistic Understanding of Iron Oxide Nanoparticles' Radiosensitizing Properties

Affiliations

Advances in the Mechanistic Understanding of Iron Oxide Nanoparticles' Radiosensitizing Properties

Indiana Ternad et al. Nanomaterials (Basel). .

Abstract

Among the plethora of nanosystems used in the field of theranostics, iron oxide nanoparticles (IONPs) occupy a central place because of their biocompatibility and magnetic properties. In this study, we highlight the radiosensitizing effect of two IONPs formulations (namely 7 nm carboxylated IONPs and PEG5000-IONPs) on A549 lung carcinoma cells when exposed to 225 kV X-rays after 6 h, 24 h and 48 h incubation. The hypothesis that nanoparticles exhibit their radiosensitizing effect by weakening cells through the inhibition of detoxification enzymes was evidenced by thioredoxin reductase activity monitoring. In particular, a good correlation between the amplification effect at 2 Gy and the residual activity of thioredoxin reductase was observed, which is consistent with previous observations made for gold nanoparticles (NPs). This emphasizes that NP-induced radiosensitization does not result solely from physical phenomena but also results from biological events.

Keywords: X-ray irradiation; biological mechanism; cancer therapy; iron oxide nanoparticles; radiosensitization; thioredoxin reductase.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment; consultancies; honoraria; stock ownership or options; expert testimony; grants or patents received or pending; or royalties.

Figures

Figure 1
Figure 1
(A) TEM image of 7 nm carboxylated IONPs; (B) TEM image of 7 nm PEGylated IONPs, the scale bar corresponds to 100 nm. (C) Comparison of size distributions (histograms fitted with a log-normal function), obtained after statistical analysis of TEM images; (D) zeta potential measurements of each sample obtained by PCS; (E) size distributions of each sample obtained by PCS.
Figure 2
Figure 2
Iron concentrations in A549 cells assessed after 6 h, 24 h and 48 h of incubation with (A) 7 nm carboxylated IONPs and (B) 7 nm IONPs PEG5000 ([Fe] = 50 µg·mL−1). Cellular iron content was quantified by the Perls’ Prussian blue stain method. Iron concentrations are expressed as mean values ± S.D for three independent experiments (Tukey test, ** p < 0.01, * p < 0.05, ns = not significant).
Figure 3
Figure 3
Confocal microscopy micrographs of iron oxide nanoparticle uptake in A549 cells and intracellular localization. Cells preincubated with 7 nm IONPs PEG5000 (left); 7 nm carboxylated IONPs (right) ([Fe] = 50 µg·mL−1) for 48 h (scale bar: 20 μm). Red channel: Rhodamine-IONPs and Blue channel: LysoTracker Blue.
Figure 4
Figure 4
Survival fractions determined by standard clonogenic assay for A549 cells pre-incubated with and without IONPs ([Fe] = 50 μg·mL−1) for (A) 6 h, (B) 24 h and (C) 48 h and irradiated by X-rays. Data are plotted as means ± SD from three independent experiments. One-way ANOVA analysis was performed for each result (Tukey test, ** p < 0.01, ns = not significant).
Figure 5
Figure 5
TrxR activity rates calculated from the slope of corresponding TrxR activity curves extracted from the measurement of absorption at 412 nm during 10 min for A549 cells treated with ([Fe] = 50 µg·mL−1) and without 7 nm carboxylated IONPs and 7 nm IONPs PEG5000 for 6 h of incubation (A,D), 24 h of incubation (B,E) and 48 h of incubation (C,F). Data are plotted as means ± SD from three independent experiments. One-way ANOVA analysis was performed for each result (Tukey test, *** p < 0.001, ns = not significant).
Figure 6
Figure 6
The amplification factor at 2 Gy obtained in A549 cells as a function of residual TrxR activity. Gold data (blue) reported by Penninckx et al. [38] showed the influence of 10 nm amino-PEG GNPs on five different cell lines, while IONP data (red) showed the influence of two IONPs on A549 cells over time. Data are plotted as means ± SD from three independent experiments. Pearson’s correlation analysis was carried out for the scatterplot (r = −0.913).

References

    1. Delaney G., Jacob S., Featherstone C., Barton M. The Role of Radiotherapy in Cancer Treatment: Estimating Optimal Utilization from a Review of Evidence-Based Clinical Guidelines. Cancer. 2005;104:1129–1137. doi: 10.1002/cncr.21324. - DOI - PubMed
    1. Borras J.M., Lievens Y., Grau C. The Need for Radiotherapy in Europe in 2020: Not Only Data but Also a Cancer Plan. Acta Oncol. 2015;54:1268–1274. doi: 10.3109/0284186X.2015.1062139. - DOI - PubMed
    1. Barnett G.C., West C.M.L., Dunning A.M., Elliott R.M., Coles C.E., Pharoah P.D.P., Burnet N.G. Normal Tissue Reactions to Radiotherapy: Towards Tailoring Treatment Dose by Genotype. Nat. Rev. Cancer. 2009;9:134–142. doi: 10.1038/nrc2587. - DOI - PMC - PubMed
    1. De Ruysscher D., Niedermann G., Burnet N.G., Siva S., Lee A.W.M., Hegi-Johnson F. Radiotherapy Toxicity. Nat. Rev. Dis. Primer. 2019;5:13. doi: 10.1038/s41572-019-0064-5. - DOI - PubMed
    1. Facoetti A., Barcellini A., Valvo F., Pullia M. The Role of Particle Therapy in the Risk of Radio-Induced Second Tumors: A Review of the Literature. Anticancer Res. 2019;39:4613–4617. doi: 10.21873/anticanres.13641. - DOI - PubMed

LinkOut - more resources